Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 September 2021 | Story Michelle Nöthling | Photo Supplied
Annemarie Le Roux.

“I love working with children.” This is one of the first things Annemarie le Roux mentions when asked to describe herself. This love for children propelled Annemarie into the field of education and she graduated in 2006 with a BEd in Foundation Phase at the UFS. Annemarie immediately immersed herself in the Deaf community, enriching the lives of children at the Thiboloha School for the Deaf in Qwaqwa and the De la Bat School for the Deaf in Worcester. 

The academic world enticed Annemarie back to the University of the Free State (UFS) and she was appointed as a junior lecturer in the Department of South African Sign Language (SASL) and Deaf Studies in 2013. Going from strength to strength, Annemarie completed her master’s degree in SASL in 2019, and published an article earlier this year that she co-wrote with Marga Stander. In this article, they found that SASL “has become an increasingly popular language that hearing university students want to learn as a second language” and subsequently explored different teaching methods used for this emerging group of interested students. 

Although now firmly established in academia, Annemarie is still committed to the practical application of SASL. “I am closely involved in student and community engagement through the SIGNALS Sign Language student association that helps empower the Deaf community and South African Sign Language.” She also interprets for the Deaf community whenever she gets an opportunity, as well as for Deaf students in class and meetings.

On the importance of Sign Language and the recognition of the Deaf community in South Africa, Annemarie believes it will open greater opportunities for development. “More people will be able to learn SASL, and it might even become a subject in school for hearing children.”

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept